ConvaTec Group PLC (LON:CTEC) has earned an average recommendation of “Hold” from the ten research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is GBX 162.50 ($2.12).
CTEC has been the subject of several analyst reports. Numis Securities reaffirmed a “buy” rating and issued a GBX 200 ($2.61) price objective on shares of ConvaTec Group in a report on Friday, May 3rd. Citigroup began coverage on ConvaTec Group in a report on Tuesday, April 30th. They set a “neutral” rating and a GBX 138 ($1.80) price target for the company. Peel Hunt reissued a “buy” rating on shares of ConvaTec Group in a report on Monday, July 29th. UBS Group boosted their price target on ConvaTec Group from GBX 129 ($1.69) to GBX 185 ($2.42) and gave the stock a “neutral” rating in a report on Tuesday, August 6th. Finally, Deutsche Bank reissued a “sell” rating on shares of ConvaTec Group in a report on Friday, July 12th.
LON CTEC traded down GBX 0.55 ($0.01) during midday trading on Thursday, hitting GBX 182.05 ($2.38). The company had a trading volume of 1,661,999 shares, compared to its average volume of 5,440,000. The stock has a market cap of $3.60 billion and a P/E ratio of 22.76. The company has a quick ratio of 1.58, a current ratio of 2.37 and a debt-to-equity ratio of 104.76. The business has a 50-day moving average of GBX 153.54. ConvaTec Group has a twelve month low of GBX 113.25 ($1.48) and a twelve month high of GBX 240.50 ($3.14).
ConvaTec Group Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.